Understanding genetic factors that affect weight loss after bariatric surgery
Official title: Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery
Run by Institut de Recerca Biomèdica de Lleida · NCT06226194 · Data updated 2026-11-12
This study is trying to find out if certain genes can help predict how well people with severe obesity will lose weight after having bariatric surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 6966 (estimated) |
| Sponsor | Institut de Recerca Biomèdica de Lleida Academic / other |
| Locations | 1 site (Lleida, Leida) |
| Status | Recruiting |
| Started | March 15, 2024 |
| Main results expected | March 15, 2027 |
| Study ends | November 29, 2028 |
| Registry record updated | March 6, 2024 |
| Trial ID | NCT06226194 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are men and women aged 18 to 65 with a BMI of 35 or higher and related comorbidities, or a BMI over 40.
✕Probably not a fit
Patients with previous gastrointestinal surgeries or those with severe medical conditions that limit healthy living may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify genetic markers that predict weight loss outcomes in patients undergoing bariatric surgery, specifically sleeve gastrectomy or gastric bypass. By analyzing a large cohort of nearly 7,000 individuals with severe obesity, the study will utilize a multi-omics approach to discover and validate these markers. The goal is to better understand why some patients respond well to surgery while others do not, which could lead to more personalized treatment strategies for obesity. The study will also include an external validation set to enhance the reliability of the findings.
Why it matters
Potential benefit: If successful, this study could lead to improved patient selection for bariatric surgery, enhancing weight loss outcomes and reducing healthcare costs associated with ineffective treatments.
How similar studies have gone: Other studies have explored genetic factors in obesity treatment, but this specific multi-omics approach in a large cohort is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women between the ages of 18 and 65 at the time of surgery * SG or RYBP as bariatric procedure. * With a BMI≥35.0 kg/m2 with one or more comorbidities or a BMI\>40.0 kg/m2 at the time of surgery. * Provision of an informed consent form signed and personally dated by the patient. * With available baseline data (anthropometric, analytical, surgical procedure, pharmacological therapies, and obesity-related comorbidities). Exclusion Criteria: * Any previous gastrointestinal surgery * Treatment with any approved antiobesity drug in Spain (orlistat, liraglutide 3.0 mg and/or naltrexone/bupropion extended release) or systemic glucocorticoids for more than 4 consecutive weeks during the 3 years following BS * End stage kidney disease (eGFR \<15 ml/min/1.73m2) or liver cirrhosis at baseline * Patients who developed any major medical conditions that limits the practice of a healthy life within normal limits (advanced cardiovascular disease or heart failure, stroke with neurological sequelae, chronic pulmonary obstructive disease with dyspnea at minimal exertion, severe joint pathology, end stage renal failure, or active cancer) * Known type 1 diabetes or LADA diabetes * Women who become pregnant during the follow-up period * Current drug or alcohol abuse * Uncontrolled psychiatric illness or eating disorders developed during the follow-up period.
Where it's running
-
IRBLleida
Lleida, Leida, Spain Recruiting
Study contacts
- Principal investigator: Miguel Angel Rubio, PhD — Instituto de Investigación Sanitaria Hospital Clínico San Carlos
- Study coordinator: Albert Lecube Torelló, PhD
- Email: alecube@gmail.com
- Phone: 0034973705183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of a diet with essential amino acids on weight loss in obese patients
This study is testing if adding essential amino acids to a low-calorie diet can help obese people lose weight while keeping their muscle mass.
-
Identifying predictors of weight loss and metabolic health after bariatric surgery
This study is trying to find out what factors can help predict how well people with insulin resistance will lose weight and improve their health after having bariatric surgery.
-
Effects of weight loss with and without exercise on metabolic health
This study is testing whether losing weight with exercise helps improve metabolic health more than just losing weight through dieting alone for people with obesity.
-
Switching a failed sleeve gastrectomy to SADI-S, RYGB, or OAGB
This tests three surgical options—SADI-S, RYGB, and OAGB—for people who regained weight after a sleeve gastrectomy to see which gives the best weight loss, complication profile, and nutritional outcomes.
-
Understanding why some patients don't lose weight after bariatric surgery
This study is trying to find out why some people don’t lose as much weight as expected after bariatric surgery, focusing on the role of gut hormones to help improve their results.
-
Effects of exercise on fat tissue in obese individuals
This study tests how exercise affects fat tissue in people with obesity to see if it can help improve their metabolism and manage weight better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.